Form 10-Q Surgery Partners, Inc. For: Sep 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
Surgery Partners (SGRY) PT Lowered to $40 at Jefferies
November 13, 2024 4:03 PM ESTJefferies analyst Brian Tanquilut lowered the price target on Surgery Partners (NASDAQ: SGRY) to $40.00 (from $47.00) while maintaining a Buy rating.
The analyst comments "Our takes post-Q3 release/call: 1) some of the stock's weakness is due to rotation out by... More
Surgery Partners (SGRY) PT Lowered to $31 at Barclays
November 13, 2024 9:44 AM ESTBarclays analyst Andrew Mok lowered the price target on Surgery Partners (NASDAQ: SGRY) to $31.00 (from $32.00) while maintaining a Equalweight rating.
The analyst comments "Free Cash Flow: SGRY has delivered about $36 mn free cash flow YTD, representing about 25% of the informal 2024 target... More
